Home › Immunoglobulin Light-chain Amyloidosis › Connecticut

Pag-aaral pangklinika para sa Immunoglobulin Light-chain Amyloidosis sa Connecticut

3 pag-aaral para sa Immunoglobulin Light-chain Amyloidosis ang naghahanap ng mga kalahok sa mga site sa Connecticut.

Mga Lungsod sa Connecticut

New Haven3 pag-aaral

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

GSK Investigational Site, New Haven

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07224672

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

Yale University, New Haven

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06569147

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
Smilow Cancer Hospital Care Center - Guilford, Guilford
at 5 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06022939

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.